Monday’s Midday Stock Update: RXi Pharmaceuticals Corp (RXII), Pacific Ethanol (PEIX), Microvision (MVIS), Actinium Pharmaceuticals (ATNM), Sunshine Heart (SSH)

By Carrie Williams

So far Monday, November 21, NASDAQ is up 0% and the S&P is up 0.44%. Here are this morning’s most active stocks: RXi Pharmaceuticals Corp (NASDAQ:RXII), Pacific Ethanol (NASDAQ:PEIX), Microvision (NASDAQ:MVIS), Actinium Pharmaceuticals (NYSE:ATNM) and Sunshine Heart (NASDAQ:SSH).

RXi Pharmaceuticals Corp is up 37.13% in midday trading to $2.35. Shares opened today at $1.71. The company has a 52-week low of $0.94 and a 52-week high of $4.35.

Pacific Ethanol is up 15.04% in midday trading to $7.65. Shares opened today at $6.65. The company has a 52-week low of $2.41 and a 52-week high of $7.70. Over the last 3 months, the insider sentiment on Pacific Ethanol has been neutral based on 24 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Microvision is up 12.68% in midday trading to $1.60. Shares opened today at $1.42. The company has a 52-week low of $0.89 and a 52-week high of $3.08. Over the last 3 months, the insider sentiment on Microvision has been neutral based on 8 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Actinium Pharmaceuticals is down -8.35% in midday trading to $0.99. Shares opened today at $1.08. The company has a 52-week low of $0.86 and a 52-week high of $3.50. Over the last 3 months, the insider sentiment on Actinium Pharmaceuticals has been neutral based on 19 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Sunshine Heart is down -7.47% in midday trading to $0.17. Shares opened today at $0.18. The company has a 52-week low of $0.15 and a 52-week high of $1.90. On the Street’s front, the average 12-month analyst price target for the stock is $4.00, marking a 2064.50% potential upside from current levels. In a report issued on November 9, The Benchmark Company analyst Jan Wald reiterated a Buy rating on SSH, with a price target of $4, which represents a potential upside of 2065% from where the stock is currently trading. In the last 30 days, insiders have sold $519 worth of SSH shares. Over the last 3 months, the insider sentiment on Sunshine Heart has been neutral based on 29 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.